about
Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy.Current treatment of antiphospholipid syndrome: lights and shadows.Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.Autoimmunity and recurrent pregnancy losses.Autoimmune diseases and pregnancy: analysis of a series of cases.High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature.Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome.Management of obstetric antiphospholipid syndrome.The management of stroke in antiphospholipid syndrome.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.Intensity of anticoagulation in the treatment of thrombosis in the antiphospholipid syndrome: a meta-analysis.Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome.Ultrasonography in pregnant women with antiphospholipid syndrome using salicylic acid and heparin.Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome.Management of antiphospholipid syndrome
P2860
Q33393109-3868ED1E-087B-4BF7-AE0A-D937E6D1A3A4Q33393738-6529278F-6C99-49CE-922D-EF8C1A400770Q33401365-2221259E-8AFE-4EE6-9A80-A74F1C59DEC7Q33423959-15B50FBF-8FB1-4209-9389-7E66F2BD2121Q34274204-0F790E8D-CAAD-45D8-9989-AECE5AF5AA28Q34447002-C6473A04-75C6-47EA-9E7C-EBC4D2C1D38CQ34476952-0A6C8348-BB09-4B9D-A5CF-3B4C699A18B2Q35008643-BDE4EC5C-24DD-47D0-A58B-2C9EE03C616CQ35651850-2E916EFC-2681-4C48-821F-ECE6E5D6F341Q36009039-434FFFF8-4618-4F0F-A28C-576AF8D90CBCQ37853050-004FD52B-A96C-448E-BAB6-0665E2512CC8Q37959314-3A01D1A1-C9C2-4618-B203-4E0B328B59ADQ37959884-F01497C9-4084-4437-A845-7954B2CD2E60Q38092150-8B99A69A-6787-40C1-BF5E-7B1A5D7ED19EQ38273875-ECA32B03-14B3-4897-8404-85F61A63C1E3Q39404443-275B3DD0-C1F1-4434-8D91-8BB19F02C370Q45899346-9B0CF6F4-7615-4939-B3BC-5A73E73A8CFCQ55340983-142E5FF0-5D1A-428C-B824-54476873B521Q57656275-24FEF809-4067-4EB4-BE91-353582B82921
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Management of antiphospholipid syndrome.
@ast
Management of antiphospholipid syndrome.
@en
Management of antiphospholipid syndrome.
@nl
type
label
Management of antiphospholipid syndrome.
@ast
Management of antiphospholipid syndrome.
@en
Management of antiphospholipid syndrome.
@nl
prefLabel
Management of antiphospholipid syndrome.
@ast
Management of antiphospholipid syndrome.
@en
Management of antiphospholipid syndrome.
@nl
P1476
Management of antiphospholipid syndrome.
@en
P2093
Josephine I Tuthill
P356
10.1016/J.JAUT.2009.05.002
P577
2009-06-25T00:00:00Z